vulva cancer

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • CNSI-Fe(II) 30 mg
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Sep 15, 2023

SLN Mapping and ICG Dye for Vulvar Cancer

Not yet recruiting
  • Vulva Cancer
  • Indocyanine green
  • Boston, Massachusetts
    Tufts Medical Center
Sep 6, 2023

ful Mutations in Solid Tumor Characterized by Next Generation

Recruiting
  • Solid Tumor
  • +13 more
    • Aviano, Pordonone, Italy
      IRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
    Sep 8, 2023

    Vulva Cancer, Vulva Tumor, Squamous Cell Cancer Trial (Pembrolizumab)

    Not yet recruiting
    • Vulva Cancer
    • +2 more
    • (no location specified)
    Mar 7, 2023

    Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)

    Not yet recruiting
    • Cervical Cancer
    • +20 more
    • E7 TCR-T cells
    • New Brunswick, New Jersey
    • +1 more
    Jan 18, 2023

    Sentinel Node Extended in Squamous Cell Vulvar Cancer

    Recruiting
    • Vulva Cancer
    • Sentinel Lymph Node
    • Sentinel node biopsy
    • Stockholm, Stockholms Lan, Sweden
    • +3 more
    Aug 17, 2022

    Breast Carcinoma, Head Neck Cancer, Melanoma (Skin) Trial in Vandoeuvre-les-Nancy (Indocyanine green, Technetium99, Optonuclear

    Recruiting
    • Breast Carcinoma
    • +9 more
    • Indocyanine green
    • +3 more
    • Vandoeuvre-les-Nancy, France
      Institut de Cancérologie de Lorraine
    Mar 29, 2022

    Vulva Cancer, Recurrent, Vulvar Squamous Cell Carcinoma, Vulva Cancer Trial (DaRT Diffusing Alpha-emitters Radiation Therapy)

    Not yet recruiting
    • Vulva Cancer, Recurrent
    • +2 more
    • DaRT Diffusing Alpha-emitters Radiation Therapy
    • (no location specified)
    Feb 17, 2021